LncRNAs: New Players in Gliomas, With Special Emphasis on the Interaction of lncRNAs With EZH2
Author:
Affiliation:
1. Department of Neurosurgery; The Second Affiliated Hospital of Anhui Medical University; Hefei China
2. Cerebral Vascular Disease Research Center; Anhui Medical University; Hefei China
3. School of Pharmacy; Anhui Medical University; Hefei China
Funder
National Science Foundation of China
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Reference139 articles.
1. Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences;Amit;Int J Clin Exp Med,2012
2. Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters;Amit;Int J Clin Exp Med,2012
3. Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma;Anwar;PLoS ONE,2012
4. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: Analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour;Astuti;Br J Cancer,2005
5. MicroRNA targeting as a therapeutic strategy against glioma;Auffinger;Curr Mol Med,2013
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genomic, epigenomic and transcriptomic landscape of glioblastoma;Metabolic Brain Disease;2024-08-24
2. Hidden regulators: the emerging roles of lncRNAs in brain development and disease;Frontiers in Neuroscience;2024-05-22
3. Recent advances in machine learning methods for predicting LncRNA and disease associations;Frontiers in Cellular and Infection Microbiology;2022-11-30
4. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma;Frontiers in Molecular Neuroscience;2022-07-22
5. The Research Progress of LncRNA MAPKAPK5-AS1 in Malignant Tumors and Other Diseases;Advances in Clinical Medicine;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3